Identification of changes in gene expression associated with minimal residual disease

Cancer and Metastasis Reviews

Volumn 18, Issue 1, 1999, Pages 3-13

  Kao, Ruey Ho ^a   Von Schlippe, Maria ^a   Francia, Giulio ^b   Powell, Jill ^a   Hart, Ian R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Gene expression; Metastasis; Minimal residual disease

Indexed keywords

DNA; PROTEIN; RNA;

ARTICLE; BLOOD; BONE MARROW; GENE EXPRESSION; GENE MUTATION; GENETIC SCREENING; HUMAN; LYMPH NODE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM, RESIDUAL;

EID: 0032824585     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006243917187     Document Type: Article

References (56)

1. Cheryl HG: Detection of minimal residual disease: Relevance for diagnosis and treatment of human malignancies. Ann Rev Med 49: 111-122, 1998
2. Meyer T, Hart IR: Mechanisms of tumour metastasis. Eur J Cancer 34: 214-221, 1998
3. Fidler IJ, Kripke ML: Metastasis results from pre-existing variant cells within a malignant tumor. Science 197: 893-895, 1977
4. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 242: 148-152, 1980
5. Sager R: Expression genetics in cancer: Shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 94: 952-955, 1997
6. Dorudi S, Sheffield JP, Poulsom R, Northover JMA, Hart IR: E-cadherin expression in colorectal cancer: An immunocytochemical and in situ hybridization study. Am J Path 142: 981-986, 1992
7. Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R, et al.: E-cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol 181: 294-300, 1997
8. Gamallo C, Palacios J, Benito N, Limeres MA, Pizarro A, Suarez A, et al.: Expression of E-cadherin in 230 infiltrating ductal breast carcinoma: Relationship to clinicopathological features. Int J Oncol 9: 1207-1212, 1996
9. Hynes RO: Integrins: versatility, modulation, and signalling in cell adhesion. Cell 69: 11-25, 1992
10. Albelda SM, Mette SA, Elder DE, Stewart RM, Damjanovich L, Herlyn M, et al.: Integrin distribution in malignant-melanoma - Association of the β3 subunit with tumor progression. Cancer Res 50: 6757-6764, 1990
11. Marshall JF, Hart IR: The role of αv-integrins in tumour progression and metastasis. Seminars in Cancer Biol 7: 129-138, 1996
12. Klein G, Klein E: Evolution of tumours and the impact of molecular oncology. Nature 315: 190-195, 1985
13. Matzku S, Wenzel A, Liu S, Zoller M: Antigenic differences between metastatic and non-metastatic BSP73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 49: 1294-1299, 1989
14. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, et al.: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma-cells. Cell 65: 13-24, 1991
15. Gunthert U: CD44 in malignant disorders. Current Topics in Microbiol and Immunol 213: 271-285, 1996
16. Johnson JP, Lehmann JM, Reithmuller G: Denovo expression of intercellular adhesion molecule-1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86: 641-644, 1989
17. Johnson JP: Cell-adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastastic disease. Cancer Met Rev 10: 11-22, 1991
18. Johnson JP, Rothbacher U, Sers C: The progression associated antigen Muc 18-A unique member of the immunoglobulin supergene family. Melanoma Res 3: 337-340, 1993
19. Kyprianou N, Issacs JT: Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with v-H-ras oncogene. Cancer Res 50: 1449-1453, 1990
20. Treiger B, Issacs JT: Expression of transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. J Urol 140: 1580-1586, 1988
21. Thorgeirsson UP, Turpeenieni-Hijanen T, Talmadge JE, Liotta LA: NIH3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5: 259-262, 1985
22. Davies BR, Barraclough R, Rudland PS: Induction of metastatic ability in a stably diploid benign rat mammary epithelial-cell line by transfection with DNA from human-malignant breast-carcinoma cell lines. Cancer Res 54: 2785-2793, 1994
23. Barraclough R, Rudland PS: The S-100-related calcium-binding protein, P9KA, and metastasis in rodent and human mammary cells. Eur J Cancer 30A: 1570-1576, 1994
24. Lloyd BH, PlattHiggins A, Rudland PS, Barraclough R: Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene 17: 465-473, 1998
25. Tulchinksky EM, Grigorian MS, Ebralidze AK, Milshina NI, Lukanidin EM: Structure of gene MTSI, transcribed in metastatic mouse tumour cells. Gene 87: 219-223, 1990
26. Hart IR, Easty D: Identification of genes controlling metastatic behaviour. Br J Cancer 63: 9-12, 1991
27. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al.: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992
28. Riopel MA, Spellerberg A, Griffin CA, Perlman EJ: Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. Cancer Res 58: 3105-3110, 1998
29. Popescu NC, Zimonjic DB: Molecular cytogenetic characterization of cancer cell alterations. Cancer Genetics and Cytogenetics 93: 10-21, 1997
30. Nishizaki T, DeVries S, Chew K, Goodson WH, Ljung BM, Thor A, et al.: Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization. Genes, Chromosomes & Cancer 19: 267-272, 1997
31. Lee SW, Tomasetto C, Sager R: Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-2829, 1991
32. Lisitsyn N, Lisitsyn N, Wigler M: Cloning the differences between two complex genomes. Science 259: 946-951, 1993
33. Wieland I, Bolger G, Wigler M: A method for difference cloning: Gene amplification following subtractive hybridization. Proc Natl Acad Sci USA 87: 2720-2724, 1990
34. Chambers AF, Hill RP: Tumor progression and metastasis. The Basic Science of Oncology (Ed 3) Tannock & Hill, 1998, pp 219-239
35. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971, 1992
36. Liang P, Averboukh L, Pardee AB: Distribution and cloning of eukaryotic messenger RNA by means of differential display: Refinements and optimization. Nucleic Acids Res 21: 3269-3257, 1993
37. Francia G, Mitchell SD, Moss SE, Hanby AM, Marshall JF, Hart IR: Identification by differential display of Annexin-VI; a gene differentially expressed during melanoma progression. Cancer Res 56: 55-58, 1996
38. Bertioli DJ, Schlichter UHA, Adams MJ, Burrow PR, Steinbib HH, Antoniw JF: An analysis of differential display shows a strong bias towards high copy number mRNAs. Nucleic Acids Res 23: 4520-4523, 1995
39. Simon HG, Risse B, Jost M, Oppenheimer S, Kari C, Rodeck U: Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells. Cancer Res 56: 3112-3117, 1996
40. Kao RH, Poulsom R, Hanby AM, Francia G, Hart IR: Identification by differential display of genes expressed in breast cancer. Br J Cancer 78: 33, 1998
41. MacDonald C, Willett B: The immortalisation of rat hepatocytes by transfection with SV40 sequences. Cytotechnology 23: 161-170, 1997
42. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational diffierences analysis of cDNA. Nucleic Acids Res 22: 5640-5648, 1994
43. Diatchenko L, Lau YFC, Campbell AP, Chenchik A, Moqadam F, Huang B, et al.: Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025-6030, 1996
44. Gruskaya N, Diatchenko L, Chenchik A, Siebert PD, Khaspckov GL, Lukyanov KA, et al.: Equalizing cDNA subtraction based on selective suppression of polymerase chain reaction: Cloning of Jurkat cell transcripts induced by phytohemaglutinin and phorbol 12-myristate 13-acetate. Anal Biochem 240: 90-97, 1996
45. Siebert PD, Chenchik A, Kellogg DE, Lukyanov KA, Lukyanov SA: An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res 23: 1087-1088, 1995
46. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 270: 484-487, 1995
47. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, et al.: Gene expression profiles in normal and cancer cells. Science 276: 1268-1272, 1997
48. Powell J: Enhanced concatemer cloning a modification to the SAGE (Serial Analysis of Gene Expression) technique. Nucleic Acids Res 26: 3445-3446, 1998
49. Scheunemann P, Hosch SB, Witter K, Putz E, Zhan R, Schneider C, et al.: Establishment and comparative characterization of two new human esophageal carcinoma cell lines derived from lymph node micrometastatic cells and autologous primary tumor. Gastroenterology 114: G2778, 1998
50. Schena M, Shalon D, Davis RW, Brown PO: Quantiative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470, 1995
51. DeRisi J, Penaland L, Brown PO, Bittner ML, Meltzer PS, Ray M, et al.: Use of cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14: 457-460, 1996
52. Welford SM, Gregg J, Chen E, Garrison D, Sorensen PH, Denny CT, et al.: Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization. Nucleic Acids Res 26: 3059-3065, 1998
53. Kang DC, LaFrance R, Su ZZ, Fisher PB: Reciprocal subtraction differential RNA display: An efficient and rapid procedure for isolating differentially expressed gene sequences. Proc Natl Acad Sci USA 95: 13788-13793, 1998
54. Wang SM, Rowley JD: A strategy for genome-wide gene analysis: Integrated procedure for gene identification. Proc Natl Acad Sci USA 95: 11909-11914, 1998
55. Kerbel RS, Waghorne C, Korczak B, Lagarde A, Breitman ML: Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Cancer Surveys 7: 597-629, 1988
56. Ross AA: Minimal residual disease in solid tumor malignancies: A review. Journal of Hematotherapy 7: 9-18, 1998